Current status of miRNA-targeting therapeutics and preclinical studies against gastroenterological carcinoma.

Shibata, Chikako; Otsuka, Motoyuki; Kishikawa, Takahiro; Yoshikawa, Takeshi; Ohno, Motoko; Takata, Akemi; Koike, Kazuhiko

Shibata, Chikako; Otsuka, Motoyuki; Kishikawa, Takahiro; Yoshikawa, Takeshi; Ohno, Motoko; Takata, Akemi; Koike, Kazuhiko.

Afiliación

Shibata C; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655 Japan.
Otsuka M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655 Japan ; Japan Science and Technology Agency, PRESTO, Kawaguchi, Saitama, 332-0012 Japan.
Kishikawa T; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655 Japan.
Yoshikawa T; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655 Japan.
Ohno M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655 Japan.
Takata A; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655 Japan.
Koike K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655 Japan.

Mol Cell Ther ; 1: 5, 2013.

Article en En | MEDLINE | ID: mdl-26056570

Palabras clave

Locked nucleic acids; MicroRNA; Miravirsen; Therapeutics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Cell Ther Año: 2013 Tipo del documento: Article Pais de publicación: Dinamarca

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google